-
Reorganization of MannKind's Development Organization
-
Delivered MIT whitepaper on Biologics
-
Facilitated 2 MIT Center for Biomedical Innovation Breakthrough workshops
-
Facilitate merger of two major pharmacuetical companies in R&D - MMD with Selectide, MMD and Hoechst into HMR, Hoechst Roussel Uclef and RPR into Aventis
-
Co-develop new organizational design with EVP for R&D major pharmaceutical company - HMR and Aventis
-
Redesign of value chain in R&D to reduce attrition, improve learning, and enhance resource allocation (4) MMD, HRM, Aventis, J&J - Janssen and PRI
-
Streamline Development Process and introduce TQM concept J&J PRI
-
Review Global Product Teams and Regulatory Alignment
-
Develop Research strategy and implementation - HMR
-
Develop IT strategy to support Research - Hoechst Marion Roussel
-
Design a structure for Investigative Pharmacokinetics - Aventis
-
Integrate Strategic Organizational Design of Knowledge Management Networks -Aventis
-
Assess R&D competencies of mid-size pharmaceutical company- Marion Merrell Dow
-
Develop Business Plan for Venture Capital Funding - PsychiatricGenomics
-
Facilitate Strategic Alignment of Alliance Management
-
Facilitate downsizing for Strategic and Tactical R&D organization (2)
-
Facilitate Five Year Strategic Planning process for Chemical Development- initial and two subsequent plans- Wyeth
-
Integration of new technology merger for combinatorial chemistry competency - Selectide
-
Reverse engineering product development - Marion Merrell Dow
-
Redesign Business Strategy for Combinatorial Biotech Company - ArQule
-
Define and implementation of Intellectual Property Strategy
-
Collaborate to deliver Integrated Portfolio and Competency Evaluation- Hoechst Marion Roussel
-
Design and Implement Knowledge Management Strategy - Aventis
-
Facilitate the creation and implementation of Knowledge Management organization
-
Develop strategic initiative and delivery of Chemical Biology Platforms for Proteases, Ion Channel and Transporters
